![Ken Macnamara](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Kenneth Macnamara is the founder of Trogenix Ltd., founded in 2023, holding the title of Chief Executive Officer & Director.
Dr. Macnamara currently holds the position of Chief Operating Officer at AskBio Inc. since 2019 and Chief Operating Officer at Synpromics Ltd.
Postes actifs de Ken Macnamara
| Sociétés | Poste | Début |
|---|---|---|
Synpromics Ltd.
 Synpromics Ltd. Chemicals: SpecialtyProcess Industries Develops and commercializes synthetic promoters to control gene expressions and regulations | Directeur des opérations | - |
AskBio Inc.
 AskBio Inc. BiotechnologyHealth Technology Engages in the development and delivery of novel protein and cellular based therapies | Directeur des opérations | 01/01/2019 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
AskBio Inc.
AskBio Inc. BiotechnologyHealth Technology Engages in the development and delivery of novel protein and cellular based therapies | Health Technology |
Synpromics Ltd.
Synpromics Ltd. Chemicals: SpecialtyProcess Industries Develops and commercializes synthetic promoters to control gene expressions and regulations | Process Industries |
